Crossing Disease Boundaries: How AI Drives Rare Disease Drug Discovery
Shuyi Chen
Abstract:This article explores the challenges and prospects of using AI to advance rare disease drug discovery. With its complex genetic basis, rare diseases require precise diagnosis and personalized treatment approaches, necessitating further development of sequencing technologies, bioinformatics tools, and data analysis algorithms. Data collection and sharing pose challenges due to the limited number of rare disease patients. Collaboration and favorable policy environments are equally crucial to drive rare disease d… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.